stage iiia rectal cancer ajcc v7
Showing 1 - 5 of 5
Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,
Active, not recruiting
- Colon Adenocarcinoma
- +18 more
- Cetuximab
- +5 more
-
Anchorage, Alaska
- +797 more
Jan 9, 2023
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,
Terminated
- Rectal Mucinous Adenocarcinoma
- +8 more
- Capecitabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Metastatic Colon Carcinoma
- +24 more
- Laboratory Biomarker Analysis
- +2 more
-
Corona, California
- +7 more
Oct 26, 2022
Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v7, Stage IIIA Rectal Cancer AJCC v7 Trial in Portland
Terminated
- Locally Advanced Rectal Carcinoma
- +4 more
- Contrast-enhanced Magnetic Resonance Imaging
- Ferumoxytol
-
Portland, OregonOHSU Knight Cancer Institute
Sep 2, 2021
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Boston
Completed
- Rectal Mucinous Adenocarcinoma
- +10 more
- Radiotherapy
- +4 more
-
Boston, MassachusettsEastern Cooperative Oncology Group
Dec 3, 2018